Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms (Q35564715)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 2015

Language	Label	Description	Also known as
English	Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms	scientific article published on February 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

Europe PubMed Central

Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

0 references

0 references

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

9

object named as

Bruno Vellas

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Catherine Helmer

5

object named as

Catherine Helmer

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

author name string

Laure Rouch

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Philippe Cestac

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Olivier Hanon

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Charlène Cool

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Béatrice Bouhanick

6

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Bernard Chamontin

7

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Jean-Franҫois Dartigues

8

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sandrine Andrieu

10

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

publication date

1 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

113-130

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Global prevalence of dementia: a Delphi consensus study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Vascular risk factors and dementia: how to move forward?

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

The age-dependent relation of blood pressure to cognitive function and dementia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Use of ramipril in preventing stroke: double blind randomised trial

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second [...]

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Antihypertensive medication use and risk of cognitive impairment: the Honolulu-Asia Aging Study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Antihypertensive medication use and incident Alzheimer disease: the Cache County Study.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Reducing the risk of dementia: efficacy of long-term treatment of hypertension.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Duration of antihypertensive drug use and risk of dementia: A prospective cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Treatment of hypertension in patients 80 years of age or older

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Does blood pressure lowering treatment prevents dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease?

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Progress in cardiovascular diseases: cognitive function in essential hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984)

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Midlife blood pressure and dementia: the Honolulu-Asia aging study.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Classification of vascular dementia in the Cardiovascular Health Study Cognition Study.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Why are stroke patients prone to develop dementia?

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Threats to the mind: aging, amyloid, and hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Calcium signalling and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Increase in single L-type calcium channels in hippocampal neurons during aging.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Intraneuronal amyloid-beta1-42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Calcium ionophore increases amyloid beta peptide production by cultured cells

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

The calpains in aging and aging-related diseases

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Linking calcium to Abeta and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Alteration in calcium channel properties is responsible for the neurotoxic action of a familial frontotemporal dementia tau mutation

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Use of calcium antagonists and cognitive decline in old age. The Leiden 85-plus study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

The role of inflammation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Telmisartan prevented cognitive decline partly due to PPAR-gamma activation

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Potential for primary prevention of Alzheimer's disease: an analysis of population-based data

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

The main cost drivers in dementia: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Antihypertensive drugs and incidence of dementia: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0230-6

21 January 2018

Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25700645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans

1 reference

https://pubmed.ncbi.nlm.nih.gov/25700645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://pubmed.ncbi.nlm.nih.gov/25700645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nimodipine for primary degenerative, mixed and vascular dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25700645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High potassium diets reduce vascular and plasma lipid peroxides in stroke-prone spontaneously hypertensive rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/25700645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://pubmed.ncbi.nlm.nih.gov/25700645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No association between hypertension and risk for Alzheimer's disease: a meta-analysis of longitudinal studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25700645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potassium inhibits free radical formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25700645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25700645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular protective effects of potassium.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25700645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/25700645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mechanism of the vasodilator action of potassium.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25700645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and Ca2+ influx in cultured hippocampal neurons

1 reference

https://pubmed.ncbi.nlm.nih.gov/25700645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/25700645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40263-015-0230-6

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35564715&oldid=2197486338"